Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

Clinical trial NCT00355121 · COMPLETED

Trial details

NCT number: NCT00355121
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningococcal Meningitis Tetanus Diphtheria Pertussis Poliomyelitis

Start date: 2006-10-01
Primary completion: 2009-06-01
Enrollment: 882

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.